Condition

Sexual Disfunction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions4

Lead sponsors shown4

Clinical trials

4 shown

Sexual Dysfunction in Women With Multiple Sclerosis (MS)NCT07193823 · 2024-07-16

RECRUITING

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual TreatmentNCT06828640 · 2024-10-16

UNKNOWN

An Educational Intervention on Medication Adverse Effects in Patients With Resistant Hypertension (HTAR-CSI)NCT07589881 · 2021-04-15

COMPLETED

True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their PartnersNCT02702453 · 2016-03-01

COMPLETED

Common interventions

Educational Intervention for Adverse Drug EffectsBEHAVIORAL1 routine careOTHER1 vaginal dilatorsDEVICE1 websiteBEHAVIORAL1

Leading sponsors

Centre Hospitalier Universitaire Saint Pierre 1 Consorci Sanitari Integral 1 Ege University 1 University of Michigan 1

Trial status mix

COMPLETED2

RECRUITING1

UNKNOWN1

Phase mix

NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.